Skip to content

Homeopathic medicines for fungal infection

Repertorial approach of treating tinea corporis using individualised homoeopathic medicines: Double-blind, randomized, placebo-controlled efficacy trial

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042077
Enrollment
128
Registered
2022-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
dosage and repetition will be maintained depending upon the i

Sponsors

D N De Homoeopathic Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from tinea corporis (B35.4) for 3 months or more, diagnosis confirmed through KOH mount test 2. Age between 18 and 65 years 3. Patients of either sex 4. Literate patients; ability to read English and/or Bengali 5. Providing written informed consent 6. Patient using topical agents for tinea lesions will be included after a washout period of two weeks

Exclusion criteria

Exclusion criteria: 1. Cases with complication like lichenification and eczematisation 2. Similar looking skin conditions; e.g., seborrheic dermatitis, pityriasis rosea and psoriasis 3. Vulnerable population ââ?¬â?? Unconscious, differently abled, terminally or critically ill patients, mentally incompetent people 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 5. Pregnant and puerperal women, lactating mothers 6. Patient under tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence 7. Self-reported immune-compromised state 8. Already undergoing homoeopathic treatment for chronic disease within last 6 months

Design outcomes

Primary

MeasureTime frame
5-D pruritus scaleTimepoint: Baseline, every month, up to 3 months

Secondary

MeasureTime frame
Dermatological life quality index (DLQI) total and subscale scoresTimepoint: Baseline, every month, up to 3 months;Skindex-29 questionnaire total and subscale scoresTimepoint: Baseline, every month, up to 3 months

Countries

India

Contacts

Public ContactSubhranil Saha

D N De Homoeopathic Medical College & Hospital

drsubhranilsaha@hotmail.com09836187425

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026